Monika Malm-Erjefalt

Summary

Affiliation: Novo Nordisk A/S
Country: Denmark

Publications

  1. ncbi Metabolism and excretion of the once-daily human glucagon-like peptide-1 analog liraglutide in healthy male subjects and its in vitro degradation by dipeptidyl peptidase IV and neutral endopeptidase
    Monika Malm-Erjefalt
    Medical and Science, GLP 1 Development, Novo Nordisk A S, Søborg, Denmark
    Drug Metab Dispos 38:1944-53. 2010

Detail Information

Publications1

  1. ncbi Metabolism and excretion of the once-daily human glucagon-like peptide-1 analog liraglutide in healthy male subjects and its in vitro degradation by dipeptidyl peptidase IV and neutral endopeptidase
    Monika Malm-Erjefalt
    Medical and Science, GLP 1 Development, Novo Nordisk A S, Søborg, Denmark
    Drug Metab Dispos 38:1944-53. 2010
    ..The lack of intact liraglutide excreted in urine and feces and the low levels of metabolites in plasma indicate that liraglutide is completely degraded within the body...